Advisory Panel Votes To Approve Flibanserin
While AASECT members gathered in Minneapolis for the 47th annual conference, a different group of people gathered to discuss the fate of flibanserin, the pharmaceutical industry's answer to the question: when will women have their own version of Viagra?